Dr. Fabian Badtke , LL.M.

Practice Group Antitrust & Competition
Practice Group Compliance & Investigations

Dr. Fabian Badtke advises national and international clients on all aspects of European and German Antitrust Law, including merger control and coordination of multijurisdictional filings, antitrust investigations (incl. e-Discovery & internal investigations), cartel damage claims and compliance-programmes (incl. e-Learning and webinars). Fabian has a particular industry know-how in the financial services sector, health care & life sciences, retail and media.

He is a Member of Studienvereinigung Kartellrecht [Antitrust Research Association]. Fabian regularly publishes on current antitrust topics. He is founder and moderator of the Antitrust Law Group @XING, an online-community for competition law (Antitrust|XING).


  • German and European Competition Law
  • German and European Merger Control
  • European Law
  • Compliance and internal investigations


  • Legal studies at the universities of Potsdam, Cambridge, Great Britain (LL.M.) and at the Humboldt-University of Berlin
  • Teaching assistent at the Trinity College, School of Law, Dublin (Ireland)
  • Experience as a lawyer in a law firm specialised in medical law in Berlin
  • Karlheinz Quack Award 2008 for the best dissertation in Corporate law, Competition Law and Intellectual Property Rights, Faculty of Law, Humboldt-University, Berlin
  • With Noerr since 2007
  • Admitted to the Berlin Chamber of Lawyers since 2006


  • Fresenius/Helios on the acquisition of 40 hospitals and 13 medical care centres from Rhoen Klinikum
  • ABN AMRO on the acquisition of Credit Suisse's private banking business in Germany
  • Advice to a large German industrial company on internal compliance investigations
  • Gazprom on the acquisition Envacom’s power supply business
  • Air Berlin on the foundation of a joint venture with CCC
  • Ongoing comprehensive competition law advice to a large European retail chain


  • Frequently recommended for Antitrust (Juve 2016/2017)
  • Recommended consultant for healthcare antitrust (Juve 2016/2017)
  • Recognised as "Antitrust-Specialist of the future", Legal 500 (2014)
  • Frequently recognised and listed as "Cartel Law Expert", Germany’s "Handelsblatt" newspaper
  • In 2008, he was awarded with the Karlheinz Quack Award for the best dissertation in corporate law, competition law and intellectual property rights by Humboldt-University Berlin.




  • Member of Studienvereinigung Kartellrecht [Antitrust Research Association]

Selected Publications

  • Should the Acquisition of Non-controlling Minority Shareholdings be Treated as Concentrations? (with Rea Diamantatou), Journal of European Competition Law and Practice, 2016, Vol. 7, No. 1, p. 3 et seq.
  • Das Kartellrecht der Bankgeschäfte, in: Bankrecht, 4. issue 2014 (Carl Heymanns Verlag)
  • Kollektive Marktbeherrschung im Kraftstoffmarkt? (with Dr. Oliver Vahrenholt), in: Zeitschrift für Wettbewerbsrecht (ZWeR) 2012, pp. 272 et seq.
  • Die Bedeutung des Kartellrechts bei M&ATransaktionen, in: Kölner Schrift zum Wirtschaftsrecht (KSzW), 2011, pp. 418 et seq.
  • Das Kartellrecht und die aktuelle Debatte um die Laufzeitverlängerung von Atomkraftwerken – eine kritische Würdigung (mit Oliver Vahrenholt), in: Wettbewerb in Recht und Praxis (WRP) 2010, pp. 852 et seq.
  • Der "Rhön-Beschluss" des BGH – endlich Klarheit bei der Zusammenschlusskontrolle von Krankenhausfusionen?, in: Zeitschrift für das gesamte Krankenhausrecht (KHR) 2008, p. 141
  • Die Anwendbarkeit der deutschen und europäischen Fusionskontrolle auf Zusammenschlüsse von Krankenhäusern, 2008 (Nomos Verlag)
  • Die kartellrechtliche Bewertung des "AOK-Modells" beim Abschluss von Rabattverträgen, in: Wirtschaft und Wettbewerb (WuW) 2007, pp. 726 et seq.
  • Should the Acquisition of Non-controlling Minority Shareholdings be Treated as Concentrations? (with Rea Diamantatou), Journal of European Competition Law of Practice, 2016,Vol.7, No.1, p.3 ff.